ieCrowd Pitch Deck: 25-Slide Breakdown

See all 25 slides of the ieCrowd pitch deck, with a slide-by-slide teardown of what the deck does well and where it falls short.

ieCrowd positions itself as an innovation commercialization platform that bridges the gap between institutional research and market-ready products. The deck outlines a three-stage lifecycle—Discover, Develop, and Deploy—leveraging shared business infrastructure to reduce capital outlays. Rather than focusing on a single product, the company showcases a diverse portfolio including mosquito-repellent technology (Kite), nano-sensors for gas detection (Nuuma), non-invasive migraine treatments (Head Pain Innovations), and sleep apnea solutions. A significant portion of the presentation is dedicate…

Key takeaways

Slide-by-Slide Analysis

Slide 1: Title Slide

The deck opens with a minimalist title slide featuring the ieCrowd logo and a blue upward-pointing arrow icon. There is no tagline or mission statement present on the cover, requiring the subsequent slides to immediately define the company's purpose.

Slide 4: Background in Commercialization

This slide serves as a combined 'Experience' and 'Team' slide. It claims 'Over 100 years of innovation commercialization experience' and lists five diverse project types, ranging from large-scale enterprise software to motion capturing for video games. The slide lists industries served, including Healthcare, Defense, and Consumer Electronics. While it features 12 headshots, it lacks names and specific roles for these individuals, which is a significant omission for a professional pitch. It also lists several awards, such as the 'Entrepreneurial Excellence Award' from Bourns College of Engineering and 'First Innovation Honoree of the Month' from the City of Riverside.

Slide 7: Commercialization Life Cycle

This slide explains the 'Capital Efficient Approach.' It breaks the business model into three phases: Discover (licensing IP with low initial outlays), Develop (using shared business infrastructure and a 'Collaborative Economy' model), and Deploy (launching via market partnerships). This is the most critical slide for understanding how ieCrowd functions as a parent entity for its subsidiaries.

Slide 10: Kite

The deck transitions into specific portfolio companies. Kite is described as a technology designed to block mosquitoes from detecting and biting humans. The stated goal is the reduction of human suffering from malaria, dengue fever, and West Nile virus. The slide uses a large lifestyle image but provides no technical details on how the 'blocking' actually works or the current stage of product development.

Slide 13: Nuuma

Nuuma focuses on nano-sensor technology for detecting airborne gases and Volatile Organic Compounds (VOCs). Unlike the Kite slide, this page provides more concrete data: the technology received $2.8MM in research funding from the NIH and other sources prior to acquisition. It also lists a patent update (two granted, five pending) and names two key personnel: Sundip Doshi as EVP and Dr. Heng Su as Research Scientist.

Slide 16: Head Pain Innovations

This subsidiary is developing a non-pharmaceutical and non-invasive technology for treating migraines and headaches. The slide is purely conceptual, offering no data on clinical trials, regulatory hurdles (like FDA approval), or the specific mechanism of action for the treatment.

Slide 19: Sleep Disorder Innovations

This slide targets the sleep apnea market, citing a statistic that 42 million people in the U.S. have sleep-disordered breathing. It notes a 2014 agreement with UCLA for exclusive licenses to patent-pending innovations. The slide explicitly states the project is in the 'early stage of its commercialization process,' signaling to investors that this is a long-term play.

Slide 22: Planned NASDAQ IPO

This is a highly unusual slide for a standard startup deck. It outlines a plan to list on the NASDAQ using BANQ, a platform for public equity crowdfunding. It lists service providers including Marcum (Auditors) and Ellenoff Grossman & Schole (Counsel). The slide includes a disclaimer that there is no assurance the IPO will be completed or accepted by NASDAQ. This indicates the deck was likely used for a Regulation A+ or similar public solicitation effort.

Slide 25: Closing Slide

The deck concludes with the logo and a URL specifically pointing to an IPO landing page (ieCrowd.com/IPO). This reinforces that the primary 'ask' of this presentation was participation in a public offering rather than a private venture capital round.

What Works Well

Clear Portfolio Structure: The deck does a good job of separating the parent company's 'platform' value from the individual 'product' value of its subsidiaries. By giving each innovation its own branded slide, the company demonstrates a repeatable process for commercialization.

Institutional Validation: Citing partnerships with UCLA and funding from the NIH and the Center for Nanoscience Innovation for Defense (CNID) provides necessary credibility for a company dealing in complex, deep-tech fields like nano-sensors and medical devices.

Market Sizing: For the health-related products, the deck uses clear, high-level statistics (e.g., 42 million people with sleep disorders) to establish the potential scale of the opportunity.

What Is Missing

Financial Transparency: There are no revenue figures, no details on the cost of licensing the IP, and no breakdown of how the 'shared infrastructure' impacts the bottom line. For a company planning an IPO, the lack of historical financial performance or a clear burn rate is a major gap.

Technical Depth: While the deck mentions 'nano-sensors' and 'non-invasive technology,' it never explains the 'how.' Investors in the life sciences or hardware space typically require at least a high-level explanation of the underlying science to assess the risk of the technology failing to work.

Competitive Landscape: The deck operates in a vacuum. There is no mention of existing mosquito repellents, current sleep apnea machines (like CPAP), or pharmaceutical competitors for migraine relief. Failing to acknowledge competition makes the 'commercialization' path seem easier than it likely is.

Detailed Team Bios: Slide 4 shows many faces but provides zero context for who they are. In early-stage or commercialization-heavy investing, the pedigree of the operators is often as important as the technology itself.

Founder Takeaways

The 'Platform' Narrative: If you are building a venture studio or a multi-product company, follow ieCrowd's lead in Slide 7. Clearly defining the 'Discover, Develop, Deploy' stages helps investors understand how you add value beyond just holding equity in other companies.

Regulatory Awareness: When pitching medical or health-related products, always include a slide or bullet points regarding the regulatory pathway (FDA, CE Mark, etc.). ieCrowd mentions 'early stage' but omits the specific hurdles required to get these products to market.

The 'Ask' Alignment: This deck is a clear example of tailoring a presentation to a specific funding vehicle. Because they were targeting an IPO/crowdfunded model, the deck focuses heavily on 'big picture' impact and institutional names rather than the granular unit economics that a professional VC would demand.

Frequently asked questions

What is ieCrowd's core business model?
ieCrowd operates as a commercialization engine. According to slide 7, they follow a 'Discover, Develop, Deploy' cycle. They license intellectual property from institutional partners with low initial costs, provide shared operations and leadership to develop these technologies into subsidiaries, and then launch products through market partnerships and distribution channels.
What specific products are in the ieCrowd portfolio?
The deck highlights four main innovations: Kite (mosquito detection blocking), Nuuma (nano-sensors for gases and VOCs), Head Pain Innovations (non-invasive migraine treatment), and Sleep Disorder Innovations (oxygenation for sleep apnea). Each is positioned as a separate brand or subsidiary under the ieCrowd umbrella.
How does ieCrowd plan to go public?
Slide 22 details a planned NASDAQ IPO. Uniquely, they intended to use BANQ, a division of TriPoint Global Equities, which is an electronic investment banking platform that features public equity crowdfunding. This suggests a strategy to leverage retail investors alongside traditional institutional methods.
What is the status of their intellectual property?
The status varies by product. For Nuuma, slide 13 notes two patents granted and five pending. For Sleep Disorder Innovations, slide 19 states they entered an agreement with UCLA in late 2014 for exclusive licenses to patent-pending innovations, noting the project is in the 'early stage' of commercialization.
What financial information is provided in the deck?
The provided slides contain almost no financial data. There are no revenue figures, profit and loss statements, or projections. The only specific dollar amount mentioned is $2.8MM in research funding received by the Nuuma technology from sources like the NIH and CNID prior to ieCrowd's acquisition (Slide 13).
Cover slide of the ieCrowd pitch deck
ieCrowd pitch deck, slide 1

ieCrowd pitch deck: the facts

Company
ieCrowd
Slides
25
Sector
Enterprise Software

ieCrowd pitch deck PDF

The full ieCrowd deck is embedded on this page and can be read slide by slide in the browser — no download or account required. Each slide is covered in the breakdown above.

What the ieCrowd (Innovation Economy Corporation) pitch deck was used for

This deck is an ieCrowd company overview used to market its “Collaborative Economy” commercialization platform for life and health innovations licensed from research institutions and inventors. It presents ieCrowd as founded in October 2010, headquartered in Riverside, CA, commercializing five innovations (including Kite and Nuuma) with a claimed $13B addressable market and having raised approximately $13M from private and strategic investors. The deck’s framing and contemporaneous media coverage around the planned IPO suggest it was used around 2015–2016 as part of a broader capital‑raising effort, including an eventual equity crowdfunding campaign and a public listing strategy. It targets impact and innovation‑oriented investors interested in diversified exposure across ieCrowd’s portfolio rather than a single product.

Business model: Parent company that acquires or licenses life and health innovations (primarily from research institutions), places them into majority‑owned subsidiaries, and uses a shared commercialization platform (operations, sales, marketing, PR, administration, capital and executive leadership) to bring products to market.

Founded
2010
Headquarters
Riverside, California, United States (1650 Spruce Street Suite 500, Riverside, CA 92507).
Industry
Health technology commercialization / enterprise innovation platform.

Round: Growth‑stage capital raise combining a planned IPO with equity crowdfunding and continued private investment around 2015–2016.

Year: 2015–2016 (period of IPO planning and Crowdfunder campaign associated with this overview narrative).

Raising: Around the time of this deck, ieCrowd was publicly described as having raised about $13M to date and planning an IPO to raise roughly four times that amount (approximately $18.8M) to fund its innovation portfolio; later, it also launched an equity crowdfunding campaign on Crowdfunder.

Total funding: Externally reported totals vary: approximately $13M in funding as of 2015 according to Nanalyze, $9.8M raised according to PitchBook, and $6.3M total investment per Crustdata.

Use of funds as presented: To expand ieCrowd’s commercialization platform and fund development, regulatory progress, manufacturing and distribution across its portfolio of life and health innovations, including mosquito‑control products and nano‑sensor technologies.

What happened after the ieCrowd (Innovation Economy Corporation) deck

ieCrowd built a portfolio of health‑focused innovations such as Kite and Nuuma, raised multiple rounds of capital including grants, crowdfunding and private investment, pursued an IPO and equity crowdfunding, and secured at least one large‑potential distribution agreement for Kite products; however, despite these steps, the company is recorded as out of business by 2021.

What the ieCrowd (Innovation Economy Corporation) deck got right

What could have been stronger

How an investor would read this deck

What draws attention

Risks that stand out

Questions this deck invites

What founders can take from the ieCrowd (Innovation Economy Corporation) deck

ieCrowd (Innovation Economy Corporation) pitch deck: common questions

What does ieCrowd do?

ieCrowd (Innovation Economy Corporation) is a Riverside, California‑based company that acquires or licenses promising life and health innovations—primarily from universities and research institutions—and places them into majority‑owned subsidiaries, which then use ieCrowd’s shared commercialization platform to bring products to market.

How much funding has ieCrowd raised and when was it founded?

According to the deck and Nanalyze’s 2015 analysis, ieCrowd was founded in October 2010 and has raised about $13M in funding; external databases report $6.3M–$9.8M in total investment, reflecting differing methodologies. The deck states the company had 33 employees at the time, with leadership experienced in running private and public companies.

What are ieCrowd’s main products featured in the pitch deck?

The deck highlights five commercialized innovations with a combined addressable market of roughly $13B, including Kite (mosquito‑behavior control technologies to reduce insect‑borne diseases) and Nuuma (a nano‑sensor “digital nose” for detecting gases at parts‑per‑billion levels). These assets are structured as subsidiaries that benefit from ieCrowd’s shared operations and commercialization infrastructure.

What fundraising round or strategy was this ieCrowd deck associated with?

Around the time of this deck, ieCrowd pursued multiple fundraising channels: traditional private investors, an announced IPO aiming to raise about 4x the prior $13M funding, and later an equity crowdfunding campaign on Crowdfunder that diversified investor exposure across its existing and future innovations. The deck itself positions ieCrowd as raising growth capital to expand its portfolio and scale commercialization of its health and safety technologies.

What ultimately happened to ieCrowd after this deck—did it succeed and is it still operating?

PitchBook reports ieCrowd as “Out of Business” with an out‑of‑business status completed on May 21, 2021. As of that profile, the company had raised $9.8M in total; there is no indication in those data that the planned IPO achieved a lasting public listing.

Sources

Funding and outcome facts on this page were researched on 2026-08-22 from the pages below.

ieCrowd pitch deck slides

ieCrowd pitch deck slide 1 of 25
ieCrowd pitch deck — slide 1 of 25
ieCrowd pitch deck slide 2 of 25
ieCrowd pitch deck — slide 2 of 25
ieCrowd pitch deck slide 3 of 25
ieCrowd pitch deck — slide 3 of 25
ieCrowd pitch deck slide 4 of 25
ieCrowd pitch deck — slide 4 of 25
ieCrowd pitch deck slide 5 of 25
ieCrowd pitch deck — slide 5 of 25
ieCrowd pitch deck slide 6 of 25
ieCrowd pitch deck — slide 6 of 25

What each slide of the ieCrowd pitch deck says

Slide 2

Certain Notices and Disclaimers Confidential Information This presentation and the information contained in this presentation is confidential and proprietary to us and is being given to you on a confidential basis. No part of this presentation or the information contained herein may be reproduced, photocopied, redistributed or passed on, directly or indirectly, to any other person, or published, in whole orin part, for any purpose. No Offer or Solicitation of Offer This presentation is for informational purposes only. This presentation does not constitute an offer to sell or a solicitation of an offer to buy any securities of the Company, nor shall it or any part of it, or the fact of its d…

Slide 4

Background in Commercialization Over 100 years of innovation commercialization experience and running private and public companies Projects + Large-scale enterprise software for secured e-commerce + Asset tracking system employing the combination of GPS, wireless and medical sensors (co-inventors on patents) + University of California, Riverside Research Park — an Innovation and research incubation park + Motion capturing devices for video games through advanced pattern recognition + Messaging systems using advanced Digital Signal Processing (DSP) Industries * Healthcare + Video games & entertainment « Defense + Telecommunications + Consumer electronics Recognitions for technology transfer…

Slide 5

Market Opportunity - Promising Untapped Innovations * From research institutions, companies and private inventors « Estimated $60 billion annually in federally funded basic and applied research in the U.S. alone* « Too many of these innovations never see the light of day *Office of Science and Technology Policy, 2015

Slide 6

Highlights . . We secure and seek to commercialize life and health innovations developed by research institutions Currently commercializing 5 innovations with addressable market of approximately $13B* Recently secured option on additional 28 patents and applications related to oncology, diabetes, bacterial infection and stroke Founded October, 2010, headquartered in Riverside, CA, and currently has 33 employees including leadership with private and public company experience Raised approximately $13M from private investors, life and health strategic investors, funds, and family office. Prior to acquisition by ieCrowd, technologies received nondilutive funding from Gates Foundation and Nation…

Slide 7

Commercialization Life Cycle — Capital Efficient Approach « Discover: Licensing/acquiring IP rights from partners leverages expertise and resources of institutional partnerships « Access to diverse pool of potential innovations « Target licensing/acquisition of IP with low initial capital outlays « Due diligence process involves IP review » Develop: Efficiencies created by shared business infrastructure and Collaborative Economy model « ieCrowd™ provides subsidiaries with operations, sales, marketing, public relations and administration functions, as well as capital and executive leadership « Collaborative Economy model leverages expertise and resources of development partners/collaborators…

Slide 10

Kite™ Kite is being designed to block mosquitoes from detecting and biting humans with a goal of reducing human suffering from malaria, dengue fever, West Nile virus, and other mosquito-borne diseases

Slide 11

Kite™ Business Focus: « Designing new product concepts aimed at lowering the spread of insect-borne diseases + Patent-pending technologies control the behavior of mosquitoes and other blood-seeking insects by manipulating carbon dioxide receptors « Prior to acquisition by ieCrowd, technology received $3MM plus in research grants from Bill and Melinda Gates Foundation and National Institutes of Health (NIH) Targeted Markets: « Kite™ is being designed for potential use in personal, home and garden, public health, vector control, pet, livestock, farm and agricultural purposes Patent Update: + Five international and U.S. patents pending Management Update: + Named Grey Frandsen as Business Unit…

Slide 12

Nuuma™ Nuuma is a tiny nano-based sensor being designed to detect airborne gases at the parts per billion (ppb) level, envisioned as a "digital nose" for mobile devices, with potential consumer and professional uses ranging from testing indoor/outdoor air quality to early disease detection to homeland security

Slide text above is read directly from the ieCrowd deck PDF embedded on this page.

Related fundraising guides (24)

This deck's categories (1)

Browse companies alphabetically (1)

Decks in the same category (12)

More pitch deck teardowns (16)

Recently published pitch deck teardowns (12)

Fundraising library · Pitch deck examples · Investor directory · Founder database